Anxiolytic activity evaluation of four medicinal plants from Cameroon

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 8, Issue 5 SUPPL., 2011, Pages 130-139

  Bum, E Ngo ^a   Soudi, S ^b   Ayissi, E R ^b   Dong, C ^b   Lakoulo, N H ^b   Maidawa, F ^b   Seke, P F E ^b   Nanga, L D ^b   Taiwe, G S ^b   Dimo, T ^b   Njikam, Njifutie ^c   Rakotonirina, A ^b   Rakotonirina, S V ^b   Kamanyi, A ^b  

^a UNIVERSITY OF NGAOUNDERE   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF DSCHANG   (Cameroon)

Author keywords

Agitation; Anxiety; Medicinal plants; Traditional medicine

Indexed keywords

ANXIOLYTIC AGENT; PLANT EXTRACT;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; BODY TEMPERATURE; CAMEROON; CHEMISTRY; CHENOPODIUM AMBROSIOIDES; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; EVALUATION; FEVER; ISOLATION AND PURIFICATION; MALE; MAZE TEST; MEDICINAL PLANT; MIMOSA; MOTOR ACTIVITY; MOUSE; PHYSIOLOGICAL STRESS; PHYTOTHERAPY; PSYCHOLOGIC TEST; TRADITIONAL MEDICINE;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CAMEROON; CHENOPODIUM AMBROSIOIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; MALE; MAZE LEARNING; MEDICINE, TRADITIONAL; MICE; MIMOSA; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PSYCHOLOGICAL TESTS; STRESS, PHYSIOLOGICAL;

EID: 84872035605     PISSN: None     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v8i5S.19     Document Type: Article

References (32)

1. Adjanohoun, J.E., Aboubakar, N., Dramane, K., Ebot, M.E., Ekpere, J.A., Enow-Orok, E.G., Focho, D., Gbile, Z.O., Kamanyi, A., Kamsu-kom, J., Keita, A., Mbenkum, T., Mbi, C.N., Mbiele, A.C., Mbome, J.C., Muberu, N.K., Nancy, W.L., Nkongmeneck, B., Satabie, B., Sofowora, A., Tamze, V., Wirmum, C.K. (1996) Traditional medicine and pharmacopoeia: Contribution to ethnobotanical and floristic studies in Cameroon. Ed. Organization of African Unity Scientific, Technical and Research Commission, Centre National de Production de Manuels Scolaires, Porto-Novo.
2. Amalraj, T., Ignacimuthu, S. (2002). Hyperglycemic effect of leaves of Mimosa pudica Linn. Fitoterapia. 73: 351-352.
3. Arbonnier, M. (2000). Arbres, arbustes et lianes des zones sèches d'Afrique de l'Ouest. Ed. Centre de Coopération Internationale en Recherche Agronomique pour le développement/Muséum national d'histoire naturelle/Union mondiale pour la nature (CIRAD/MNHN/UICN), Paris.
4. Benie, T., Thieulant, M.L. (2004). Mechanisms underlying antigonadotropic effects of some traditional plant extracts in pituitary cell culture. Phytomedicine. 11: 157-164.
5. Borsini, F., Lecci, A., Volterra, G., Meli, A. (1989). A model to measure anticipatory anxiety in mice? Psychopharmacology. 98: 207-211.
6. Bourin, M., Dhonnchadha, B.A., Colombel, M.C., Dib, M., Hascoet, M. (2001). Cyamemazine as an anxiolytic drug on the elevated plus maze and Light/dark paradigm in mice. Behavioral Brain Res. 124: 87-95.
7. Bouwknecht, J.A., Olivier, B., Paylor, R.E. (2007). The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci. Biobehav. Rev. 31: 41-59.
8. Craske, M.G., Waters, A.M. (2005). Panic disorder, phobias, and generalized anxiety disorder. Annu. Rev. Clin. Psychol. 1: 197-225.
9. Dalziel, J.M. (1937). The useful plants of West Tropical Africa. Ed. The Crown Agency for the Colonies, London.
10. File, S.E., Wardill, A.G. (1975). Validity of head dipping as a measure of exploration in a modified hole board. Psychopharmacologia. 44: 53-59.
11. Ganguly, M., Devi, N., Mahanta, R., Borthakur, M.K. (2007). Effect of Mimosa pudica root extract on vaginal estrous and serum hormones for screening of antifertility activity in albino mice. Contraception. 76: 482-485.
12. Gilliy, Y.G., Gleiser, R.M., Zygadlo, J.A. (2008). Mosquito repellent activity of essential oils of aromatic plants growing in Argentina. Bioresour. Technol. 99: 2507-2515.
13. Grant, B.F., Hasin, D.S., Stinson, F.S., Dawson, D.A., June Ruan, W., Goldstein, R.B., Smith, S.M., Saha, T.D., Huang, B. (2005). Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 35: 1747-1759.
14. Haruna, A.K. (2000). Depressant and anticonvulsant properties of the root decoction of Afrormosia laxiflora (Leguminosae). Phytother. Res. 14: 57-59.
15. Jardin, C.M., Jham, G.N., Dhingra, O.D., Treire, M.M. (2008). Composition and antifungal activity of the essential oil of the Brazilian Chenopodium ambrosioides L. J. Chem. Ecol. 34: 1213-1218.
16. Jenck, F., Moreau, J.L., Martin, J.R., Kilpatick, G.J., Reinsheid, R.K., Monsma, F.J., Nothaker, H.P., Civelli, O. (1997). Orphanin FG acts as an anxiolytic to attenuate behavioural responses to stress. Proc. Natl. Acad. Sci. USA. 94: 14854-14858.
17. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E. (2005). Lifetime prevalence and ageof-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. ArchGen. Psychiatry. 62: 593-602.
18. Kessler, R.C. (2007). The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective. J. Clin. Psychiatry. 68: 10-19.
19. Kumar, R., Mishra, A.K., Dubey, N.K., Tripathi, Y.B. (2007). Evaluation of Chenopodium ambrosioides oil as a potential source of antifungal, antiaflatoxigenic and antioxidant activity. Int. J. Food Microbiol. 115: 159-164.
20. Lecci, A., Borsini, F., Volterra, G., Meli, A. (1990). Pharmacological validation of a novel animal model of anticipatory anxiety in mice. Psychopharmacolavogy. 101: 255-261.
21. Lister, R.G. (1987). The use of a plus-maze to measure anxiety in mouse. Psychopharmacology. 92: 180-185.
22. Monzote, L., Garcia, M., Montalvo, A.M., Scull, R., Miranda, M., Abreu, J. (2007). In vitro activity of an essential oil against Leishmania donovani. Phytother. Res. 21: 1055-1058.
23. Ngo Bum, E., Dawack, D.L., Schmutz, M., Rakotonirina, A., Rakotonirina, S.V., Portet, C., Jeker, A., Olpe, H.R., Herrling, P. (2004). Anticonvulsant activity of Mimosa pudica decoction. Fitoterapia. 75: 310-315.
24. Ngo Bum, E., Taiwe, G.S., Nkainsa, L.A., Moto, F.C.O., Seke Etet, P.F., Hiana, I.R., Bailabar, T., Rouyatou, Papa Seyni, Rakotonirina, A., Rakotonirina, S.V. (2009a). Validation of anticonvulsant and sedative activity of six medicinal plants. Epilepsy Behav. 14: 454-458.
25. Ngo Bum, E., Taiwe, G.S., Moto, F.C.O., Ngoupaye, G.T., Nkantchoua, G.C.N., Pelanken, M.M., Rakotonirina, S.V., Rakotonirina, A. (2009b). Anticonvulsant, anxiolytic and sedative properties of the roots of Nauclea latifolia Smith in mice. Epilepsy Behav. 15: 434-440.
26. Olivier, B., Zethof, T., Pattij, T., Van Boogaert, M., Van Oorschot, R., Leahy, C., Oosting, R., Bouwknecht, A., Veening, J., Van der Gugten, J., Groenink, L. (2003). Stress-induced hyperthermia and anxiety: pharmacological validation. Eur. J. Pharmacol. 463: 117-132.
27. Pousset, J.L. (1989). Plantes médicinales africaines. Ed. Marketing, ACCT, Paris.
28. Rodgers, R.J., Cao, B.J., Dalvi A., Holmes, A. (1997). Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30: 289-304.
29. Sundgren-Andersson, A.K., Östlund, P., Bartfai, T. (1998). Simultaneous Measurement of Brain and Core Temperature in the Rat during Fever, Hyperthermia, Hypothermia and Sleep. NeuroImmunoModulation. 5: 241-247.
30. Tunnicliff, G. (1991). Molecular basis of buspirone's anxiolytic action. Pharmacol Toxicol. 69: 149-156.
31. Valsala, S., Karpagaganapathy P.R. (2002). Effect of Mimosa pudica root powder on oestrous cycle and ovulation in cycling female albino rat, Rattus norvegicus. Phytother. Res.16: 190-192.
32. Vinkers, C.H., Meg, J.V., Bogaert, V., Klanker, M., Mechiel Korte, S., Oosting, R., Hanania, T., Hopkins, S.C., Olivier, B., Groenink, L. (2008). Translational aspects of pharmacological research into anxiety disorders: The stress-induced hyperthermia (SIH) paradigm. Eur. J. Pharmacol. 585: 407-425.